COMMUNIQUÉS West-GlobeNewswire

PHAXIAM Therapeutics annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription de 7,8 M€
27/06/2024
Lyon (France), le 27 juin 2024 - 17h45 CEST - PHAXIAM Therapeutics (la « Société »), société biopharmaceutique qui développe des traitements innovants contre les infections bactériennes sévères et résistantes, annonce [...]
Nicox: 2024 Ordinary Shareholder Meeting
27/06/2024
Press Release Nicox: 2024 Ordinary Shareholder Meeting June 27, 2024 – release at 17:30 CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, ALCOX), an international ophthalmology company, informs its [...]
Nicox : Assemblée Générale Ordinaire 2024
27/06/2024
Communiqué de presse Nicox : Assemblée Générale Ordinaire 2024 27 juin 2024 – diffusion à 17h30 Sophia Antipolis, France Nicox SA (Euronext Paris : FR0013018124, ALCOX, éligible PEA-PME), société internationale [...]
CloudMD Securityholders Approve Go-Private Transaction with CPS Capital
27/06/2024
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “ Company ” or “ CloudMD ”), an innovative health services company transforming the delivery of care, is [...]
Dermatology Group of Arkansas Member Earns Nursing Degree
27/06/2024
Savannah Norwood completed her master’s degree while working at Dermatology Group of Arkansas and is now a nurse practitioner at the respected practice serving the entire Little Rock area LITTLE ROCK, Ark., June 27, [...]
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
27/06/2024
The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Recommendation is based on pre-clinical and epidemiological data showing [...]
LSL Pharma Group Secures $1.5 Million as the First Closing of Its Non-Brokered Private Placement
27/06/2024
BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced that it has met the closing [...]
Nexstim Plc Has Agreed on a Digitalization and Innovation Loan with Finnvera to Finance Product Development Project
27/06/2024
Company Announcement, Helsinki, 27 June 2024 at 4:45 PM (EEST) Nexstim Plc Has Agreed on a Digitalization and Innovation Loan with Finnvera to Finance Product Development Project Nexstim Plc (NXTMH:HEX) ("Nexstim" or " [...]
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
27/06/2024
Nearly 20 studies have successfully leveraged Science 37's medical and operational expertise to boost patient recruitment and enrollment activities RESEARCH TRIANGLE PARK, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Science [...]
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
27/06/2024
GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025 GTB-5550 TriKE ® IND submission for treatment of B7H3 positive solid tumors expected in Q1 2025 GTB-5550 Phase 1 dose [...]
KFSH&RC Leads Global Healthcare Revolution with AI and Robotics
27/06/2024
RIYADH, Saudi Arabia, June 27, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH&RC) is at the forefront of the global AI and robotics revolution. These technological advancements [...]
bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
27/06/2024
bioLytical Laboratories Inc. helps boost testing efforts across the country with free HIV rapid test donations to KFF and the Greater Than HIV campaign to support testing efforts nationwide Donated rapid tests will be [...]
Quanta Announces Dosing of First Patient in Phase 1/1b Clinical Trial of QTX3046, an Oral KRASᴳ¹²ᴰ-Selective Dual-State Allosteric Inhibitor, and Other Program Updates
27/06/2024
– Phase 1 clinical trial underway evaluating QTX3046, a novel orally bioavailable and brain-penetrant, non-covalent allosteric G12D-selective-KRAS dual (OFF/ON)-state inhibitor, in patients with KRAS G12D -mutated [...]
GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators
27/06/2024
Company is strategically building a global patent estate in key territories for a growing pipeline targeting potentially high-value indications in need of innovation LA JOLLA, CA, June 27, 2024 (GLOBE NEWSWIRE) -- GRI [...]
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
27/06/2024
BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that on June 5, 2024 [...]
AssureCare Expands Collaboration with Large Blues Plan to Implement Its Revolutionary Business Intelligence Platform, Akumen™
27/06/2024
Akumen, a transformational analytics platform, enables health plans to optimize their clinical and administrative operations CINCINNATI, June 27, 2024 (GLOBE NEWSWIRE) -- AssureCare , a leading provider of healthcare [...]
NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation
27/06/2024
LANGHORNE, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
Inmagene Announces Positive Topline Results of a Multiple Ascending Dose (MAD) Study of IMG-004, a Non-covalent Reversible BTK Inhibitor with Once Daily Dosing Potential
27/06/2024
IMG-004 was well tolerated across once daily (QD) doses ranging 50 mg to 300 mg for 10 days. Key liver function parameters remained within the normal reference range for all tested doses. No reports of bleeding events [...]
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering
27/06/2024
ACTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve [...]

Pages